Vascular permeability factor, an endothelial cell mitogen related to PDGF
- PMID: 2479987
- DOI: 10.1126/science.2479987
Vascular permeability factor, an endothelial cell mitogen related to PDGF
Abstract
Vascular permeability factor (VPF) is a 40-kilodalton disulfide-linked dimeric glycoprotein that is active in increasing blood vessel permeability, endothelial cell growth, and angiogenesis. These properties suggest that the expression of VPF by tumor cells could contribute to the increased neovascularization and vessel permeability that are associated with tumor vasculature. The cDNA sequence of VPF from human U937 cells was shown to code for a 189-amino acid polypeptide that is similar in structure to the B chain of platelet-derived growth factor (PDGF-B) and other PDGF-B-related proteins. The overall identity with PDGF-B is 18%. However, all eight of the cysteines in PDGF-B were found to be conserved in human VPF, an indication that the folding of the two proteins is probably similar. Clusters of basic amino acids in the COOH-terminal halves of human VPF and PDGF-B are also prevalent. Thus, VPF appears to be related to the PDGF/v-sis family of proteins.
Similar articles
-
Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.J Clin Invest. 1989 Nov;84(5):1470-8. doi: 10.1172/JCI114322. J Clin Invest. 1989. PMID: 2478587 Free PMC article.
-
Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies.Arch Biochem Biophys. 1993 Feb 15;301(1):15-20. doi: 10.1006/abbi.1993.1109. Arch Biochem Biophys. 1993. PMID: 8442657
-
Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGF.Biochim Biophys Acta. 1995 Jan 5;1246(1):1-9. doi: 10.1016/0167-4838(94)00144-6. Biochim Biophys Acta. 1995. PMID: 7811723
-
Vascular permeability factor: a unique regulator of blood vessel function.J Cell Biochem. 1991 Nov;47(3):219-23. doi: 10.1002/jcb.240470306. J Cell Biochem. 1991. PMID: 1791186 Review.
-
Vascular permeability factor, tumor angiogenesis and stroma generation.Invasion Metastasis. 1994-1995;14(1-6):385-94. Invasion Metastasis. 1994. PMID: 7544775 Review.
Cited by
-
Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs.Front Cell Dev Biol. 2020 Jul 7;8:584. doi: 10.3389/fcell.2020.00584. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32775327 Free PMC article. Review.
-
Tumors: wounds that do not heal-redux.Cancer Immunol Res. 2015 Jan;3(1):1-11. doi: 10.1158/2326-6066.CIR-14-0209. Cancer Immunol Res. 2015. PMID: 25568067 Free PMC article. Review.
-
VEGF -634C/G genotype is predictive of long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.Int J Med Sci. 2012;9(10):833-7. doi: 10.7150/ijms.4914. Epub 2012 Nov 1. Int J Med Sci. 2012. PMID: 23155356 Free PMC article.
-
Splicing in oncogenesis and tumor suppression.Cancer Sci. 2012 Sep;103(9):1611-6. doi: 10.1111/j.1349-7006.2012.02356.x. Epub 2012 Jul 24. Cancer Sci. 2012. PMID: 22691055 Free PMC article. Review.
-
Micron-scale spatially patterned, covalently immobilized vascular endothelial growth factor on hydrogels accelerates endothelial tubulogenesis and increases cellular angiogenic responses.Tissue Eng Part A. 2011 Jan;17(1-2):221-9. doi: 10.1089/ten.TEA.2010.0202. Epub 2010 Oct 7. Tissue Eng Part A. 2011. PMID: 20712418 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases